Edition:
India

Moleculin To Seek Accelerated FDA Approval And Plans For Pivotal Phase 2 Aml Trial


Wednesday, 5 Feb 2020 

Moleculin Biotech Inc ::MOLECULIN TO SEEK ACCELERATED FDA APPROVAL AND PLANS FOR PIVOTAL PHASE 2 AML TRIAL.MOLECULIN BIOTECH INC - MOLECULIN WILL CONTINUE TO FOCUS COMPANY'S EFFORTS ON EUROPEAN TRIAL TO ESTABLISH AN RP2D.MOLECULIN BIOTECH INC - INTENDS TO ENTER DISCUSSIONS WITH FDA AND EMA ABOUT CONDUCTING A SINGLE ARM PHASE 2 STUDY.MOLECULIN BIOTECH INC - U.S. PHASE 1 TRIAL MET ITS PRIMARY ENDPOINT, DEMONSTRATING SAFETY OF ANNAMYCIN IN AML PATIENTS.